Ginger Graham - Walgreens Boots Independent Director
WBA Stock | USD 17.59 0.04 0.23% |
Director
Ms. Ginger L. Graham serves as Independent director of the Company. Ms. Graham is the former President and Chief Executive Officer of Two Trees Consulting, Inc., a healthcare and executive leadership consulting firm, where she served from November 2007 to December 2016. She previously served as Senior Lecturer at Harvard Business School from October 2009 to June 2012. She also previously served as President and Chief Executive Officer of Amylin Pharmaceuticals, a biopharmaceutical company, where she also served as a director from 1995 to 2009. From 1994 to 2003, she held various positions at Guidant Corporationrationration, a cardiovascular medical device manufacturer, including Group Chairman, Office of the President, President of the Vascular Intervention Group, and Vice President. Ms. Graham has served on the board of directors of Genomic Health, Inc. since 2008 and the board of directors of Clovis Oncology, Inc. since 2013. She also serves on the board of directors of a number of privatelyheld companies.
Age | 62 |
Address | 108 Wilmot Road, Deerfield, IL, United States, 60015 |
Phone | 847 315 3700 |
Web | https://www.walgreensbootsalliance.com |
Walgreens Boots Management Efficiency
The company has Return on Asset of 0.0112 % which means that on every $100 spent on assets, it made $0.0112 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.5719) %, meaning that it generated no profit with money invested by stockholders. Walgreens Boots' management efficiency ratios could be used to measure how well Walgreens Boots manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.06. The current year's Return On Capital Employed is expected to grow to -0.1. At present, Walgreens Boots' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 98 B, whereas Total Current Assets are forecasted to decline to about 9.2 B.Similar Executives
Found 12 records | DIRECTOR Age | ||
Seshadri Chari | Fire Flower Holdings | N/A | |
Leslie Campbell | PetMed Express | 58 | |
Ju Li | Bimi International Medical | 39 | |
Mia Ching | Bimi International Medical | 49 | |
Ronald Korn | PetMed Express | 77 | |
Donald Wright | Fire Flower Holdings | N/A | |
Changqing Yan | Bimi International Medical | N/A | |
Gian Fulgoni | PetMed Express | 69 | |
Sharon Ranson | Fire Flower Holdings | N/A | |
Fengsheng Tan | Bimi International Medical | N/A | |
Frank Formica | PetMed Express | 73 | |
Norman Inkster | Fire Flower Holdings | N/A |
Management Performance
Return On Equity | -0.57 | ||||
Return On Asset | 0.0112 |
Walgreens Boots Alliance Leadership Team
Elected by the shareholders, the Walgreens Boots' board of directors comprises two types of representatives: Walgreens Boots inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Walgreens. The board's role is to monitor Walgreens Boots' management team and ensure that shareholders' interests are well served. Walgreens Boots' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Walgreens Boots' outside directors are responsible for providing unbiased perspectives on the board's policies.
Alexander Gourlay, Executive VP and President of Walgreens Co | ||
James Skinner, Executive Chairman | ||
David Brailer, Independent Director | ||
Joseph Amsbary, Senior Secretary | ||
Leonard Schaeffer, Independent Director | ||
Nancy Schlichting, Independent Director | ||
Dominic Murphy, Director | ||
Jan Reed, Senior Vice President General Counsel, Corporatye Secretary | ||
James Kehoe, Global CFO, Executive Vice President - Global | ||
Anthony Roberts, Senior Vice President Global CIO | ||
Holly May, Ex Officer | ||
Beth Leonard, Senior Officer | ||
Marco Pagni, Executive Vice President Global Chief Legal and Administrative Officer | ||
Timothy Wentworth, CEO Director | ||
John Lederer, Director | ||
Ken Murphy, Executive Vice President of Walgreens Boots Alliance and Presidentident of Global Brands | ||
Stefano Pessina, Executive Vice Chairman and CEO | ||
Simon Roberts, Executive Vice President of Walgreens Boots Alliance and President of Boots | ||
Matthew DAmbrosio, Senior Officer | ||
Rick Gates, Senior Co | ||
Neal Sample, Executive Officer | ||
Gerald Gradwell, IR Contact Officer | ||
Rosalind Brewer, CEO Director | ||
Tracey Brown, President VP | ||
Heather Dixon, Senior Vice President Chief Accounting Officer, Global Controller | ||
Kimberly Scardino, Senior Vice President Chief Accounting Officer, Global Controller | ||
Kathleen WilsonThompson, Executive Vice President Global Chief Human Resources Officer | ||
Hsiao Wang, VP Officer | ||
Jeffrey Berkowitz, Executive Vice President of Walgreens Boots Alliance and Presidentident of Pharma and Global Market Access | ||
Ornella Barra, Executive Vice President of Walgreens Boots Alliance and Presidentident and Chief Executive of Global Wholesale and International Retail | ||
Barry Rosenstein, Independent Director | ||
Mia Scholz, Sr Operations | ||
John Driscoll, Executive Healthcare | ||
Jose Almeida, Director | ||
Tiffany Kanaga, Vice Relations | ||
Janice Babiak, Independent Director | ||
Liyue Wu, Head Asia | ||
Danielle Gray, Ex Officer | ||
Manmohan Mahajan, Executive CFO | ||
Todd Heckman, Interim VP | ||
William Foote, Lead Independent Director | ||
Ginger Graham, Independent Director | ||
Aaron Radelet, Global VP | ||
Natasha Polster, Compliance Quality | ||
Aidan Clare, Senior Treasurer | ||
George Fairweather, Global CFO and Executive VP | ||
Elizabeth Burger, Executive Officer |
Walgreens Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Walgreens Boots a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.57 | ||||
Return On Asset | 0.0112 | ||||
Profit Margin | (0.04) % | ||||
Operating Margin | 0.02 % | ||||
Current Valuation | 51.05 B | ||||
Shares Outstanding | 862.71 M | ||||
Shares Owned By Insiders | 17.35 % | ||||
Shares Owned By Institutions | 61.92 % | ||||
Number Of Shares Shorted | 35.22 M | ||||
Price To Earning | 8.10 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Walgreens Boots Alliance offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Walgreens Boots' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Walgreens Boots Alliance Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Walgreens Boots Alliance Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Walgreens Boots Alliance. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Walgreens Boots Alliance information on this page should be used as a complementary analysis to other Walgreens Boots' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Walgreens Stock analysis
When running Walgreens Boots' price analysis, check to measure Walgreens Boots' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Walgreens Boots is operating at the current time. Most of Walgreens Boots' value examination focuses on studying past and present price action to predict the probability of Walgreens Boots' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Walgreens Boots' price. Additionally, you may evaluate how the addition of Walgreens Boots to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stocks Directory Find actively traded stocks across global markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is Walgreens Boots' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Walgreens Boots. If investors know Walgreens will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Walgreens Boots listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.59) | Dividend Share 1.69 | Earnings Share (7.00) | Revenue Per Share 167.542 | Quarterly Revenue Growth 0.063 |
The market value of Walgreens Boots Alliance is measured differently than its book value, which is the value of Walgreens that is recorded on the company's balance sheet. Investors also form their own opinion of Walgreens Boots' value that differs from its market value or its book value, called intrinsic value, which is Walgreens Boots' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Walgreens Boots' market value can be influenced by many factors that don't directly affect Walgreens Boots' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Walgreens Boots' value and its price as these two are different measures arrived at by different means. Investors typically determine if Walgreens Boots is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Walgreens Boots' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.